{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:16:34Z","timestamp":1791400594536,"version":"4.3.3"},"reference-count":28,"publisher":"BMJ","issue":"11","funder":[{"name":"Samsung Medical Center","award":["SMX1230441"],"award-info":[{"award-number":["SMX1230441"]}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"crossref","award":["HN22C0414"],"award-info":[{"award-number":["HN22C0414"]}],"id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MEDIPOST","award":["PHO0133531"],"award-info":[{"award-number":["PHO0133531"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2023,7,3]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We previously performed a phase II randomised double-blind clinical trial of mesenchymal stromal cell (MSCs) transplantation to prevent bronchopulmonary dysplasia in extremely premature infants. Subsequently, we followed the infants enrolled in this clinical trial to determine the safety and effectiveness of MSCs against bronchopulmonary dysplasia at 5-year follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated infants at 5 years of age receiving placebo or MSCs in a prospective follow-up study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In terms of the primary end point of composite respiratory morbidities, including respiratory problem-related readmission, emergency department visits or oxygen therapy, the MSC group had a rate of 60.7% for composite morbidities, while the control group showed a tendency of higher rate of 83.9% for the same outcomes without statistical significance. In terms of the secondary outcomes, the MSC group infants showed a tendency of being less likely to visit emergency department (control 67.7% vs MSC 35.7%) and to receive oxygen therapy (control 29.0% vs MSC 3.6%). No difference was observed in the incidence of respiratory problem-related hospital readmission or wheezing episodes between the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Intratracheally instilled MSCs showed the possibility of potential to decrease respiratory symptom-related emergency department visits and oxygen therapy episodes in infants born extremely preterm during the 5 years after a phase II randomised controlled, double-blind trial of MSCs transplantation for bronchopulmonary dysplasia. This small size study suggests preliminary insights that can be further tested using larger sample sizes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01897987\">NCT01897987<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2022-219622","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:20:20Z","timestamp":1692624020000},"page":"1105-1110","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["Five-year follow-up of phase II trial of stromal cells for bronchopulmonary dysplasia"],"prefix":"10.1136","volume":"78","clinical-trial-number":[{"clinical-trial-number":"nct01897987","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01897987","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1821-3173","authenticated-orcid":false,"given":"So Yoon","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Sil","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sein","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Rhan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Soon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"2024051320373108000_78.11.1105.1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.140830"},{"key":"2024051320373108000_78.11.1105.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.07.045"},{"key":"2024051320373108000_78.11.1105.3","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-203079"},{"key":"2024051320373108000_78.11.1105.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1806OC"},{"key":"2024051320373108000_78.11.1105.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2020.105275","article-title":"Neurodevelopmental outcomes in very Preterm infants: the role of severity of Bronchopulmonary dysplasia","volume":"152","author":"Gallini","year":"2021","journal-title":"Early Hum Dev"},{"key":"2024051320373108000_78.11.1105.6","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2013.54.2.416"},{"key":"2024051320373108000_78.11.1105.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2015.03.008"},{"key":"2024051320373108000_78.11.1105.8","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0385OC"},{"key":"2024051320373108000_78.11.1105.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052419","article-title":"Timing of umbilical cord blood derived Mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal Hyperoxic lung injury","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"key":"2024051320373108000_78.11.1105.10","doi-asserted-by":"publisher","DOI":"10.3727\/096368911X565038a"},{"key":"2024051320373108000_78.11.1105.11","doi-asserted-by":"publisher","DOI":"10.3727\/096368909X471189"},{"key":"2024051320373108000_78.11.1105.12","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0330"},{"key":"2024051320373108000_78.11.1105.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.12.011"},{"key":"2024051320373108000_78.11.1105.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1997.tb07414.x"},{"key":"2024051320373108000_78.11.1105.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03644-7","article-title":"Definitions of Bronchopulmonary dysplasia and long-term outcomes of extremely Preterm infants in Korean neonatal network","volume":"11","author":"Jeon","year":"2021","journal-title":"Sci Rep"},{"key":"2024051320373108000_78.11.1105.16","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00510","article-title":"Health care burden of Bronchopulmonary dysplasia among extremely Preterm infants","volume":"7","author":"Mowitz","year":"2019","journal-title":"Front Pediatr"},{"key":"2024051320373108000_78.11.1105.17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1695-4033(04)78231-4","article-title":"[Respiratory morbidity after hospital discharge in premature infants born at < or = 32 weeks gestation with Bronchopulmonary dysplasia]","volume":"60","author":"P\u00e9rez P\u00e9rez","year":"2004","journal-title":"An Pediatr (Barc)"},{"key":"2024051320373108000_78.11.1105.18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.aller.2017.02.004","article-title":"Bronchopulmonary dysplasia as a risk factor for asthma in school children and adolescents: A systematic review","volume":"46","author":"P\u00e9rez Tarazona","year":"2018","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2024051320373108000_78.11.1105.19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","article-title":"Bronchopulmonary dysplasia","volume":"5","author":"Th\u00e9baud","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2024051320373108000_78.11.1105.20","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23520"},{"key":"2024051320373108000_78.11.1105.21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1164\/rccm.201212-2236LE","article-title":"The importance of family history in asthma during the first 27 years of life","volume":"188","author":"Paaso","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2024051320373108000_78.11.1105.22","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200109000-00019"},{"key":"2024051320373108000_78.11.1105.23","doi-asserted-by":"crossref","first-page":"15077","DOI":"10.1038\/npjpcrm.2015.77","article-title":"Factors associated with the time to the first wheezing episode in infants: a cross-sectional study from the International study of wheezing in infants (EISL)","volume":"26","author":"Pacheco-Gonzalez","year":"2016","journal-title":"NPJ Prim Care Respir Med"},{"key":"2024051320373108000_78.11.1105.24","doi-asserted-by":"publisher","DOI":"10.1159\/000100086"},{"key":"2024051320373108000_78.11.1105.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2018.09.013"},{"key":"2024051320373108000_78.11.1105.26","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/ppul.25381","article-title":"Neurodevelopmental outcomes of infants with Bronchopulmonary dysplasia","volume":"56","author":"DeMauro","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"2024051320373108000_78.11.1105.27","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2016.88"},{"key":"2024051320373108000_78.11.1105.28","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3345\/cep.2020.00640","article-title":"Development of the Korean developmental screening test for infants and children (K-DST)","volume":"63","author":"Chung","year":"2020","journal-title":"Clin Exp Pediatr"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2022-219622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T23:52:24Z","timestamp":1715644344000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2022-219622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,10,17]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/thorax-2022-219622"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2022-219622","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]}}}